Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study
The United States (US) Expanded Access Program (EAP) to coronavirus disease 2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. While randomized clinical trials were in var...
Uloženo v:
Podobné jednotky
Retroperitoneal access for robotic renal surgery
Autor: Anderson, Barrett G., a další
Vydáno: (2018)
Autor: Anderson, Barrett G., a další
Vydáno: (2018)
Podobné jednotky
-
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study
Autor: Senefeld, Jonathon W., a další
Vydáno: (2021) -
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma
Autor: Senefeld, Jonathon W., a další
Vydáno: (2021) -
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
Autor: Kunze, Katie L., a další
Vydáno: (2021) -
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
Autor: Katie L. Kunze, a další
Vydáno: (2021) -
Safety Update
Autor: Michael J. Joyner, a další
Vydáno: (2020)